Sorry, no content matched your criteria.
Featured Story
This Top Biotech Stock Just Got a $100 Billion "Buy" Signal
Global cancer spending topped $100 billion for the first time after climbing a whopping 10% in 2014.
And that's a major "buy" signal for one of the top biotech stock picks we've been recommending at Money Morning.
According to a report from the IMS Institute of Health, rising drug prices and increased incidence of cancer led to the 10% spike in drug spending last year.
Global cancer spending topped $100 billion for the first time after climbing a whopping 10% in 2014.
And that's a major "buy" signal for one of the top biotech stock picks we've been recommending at Money Morning.
According to a report from the IMS Institute of Health, rising drug prices and increased incidence of cancer led to the 10% spike in drug spending last year.